John R. Mackey
BC Cancer Agency(CA)University of Alberta(CA)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Cancer survivorship and care, Breast Cancer Treatment Studies, Childhood Cancer Survivors' Quality of Life
Most-Cited Works
- → Adjuvant Trastuzumab in HER2-Positive Breast Cancer(2011)2,750 cited
- → The clonal and mutational evolution spectrum of primary triple-negative breast cancers(2012)2,008 cited
- → Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial(2007)1,159 cited
- → Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment(2009)1,092 cited
- → Adjuvant Docetaxel for Node-Positive Breast Cancer(2005)951 cited
- Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.(2002)
- → Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma